Jeff Yass’s Century Therapeutics IPSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18.1K Sell
10,605
-105,187
-91% -$215K ﹤0.01% 13146
2026
Q2
$284K Sell
115,792
-110,895
-49% -$253K ﹤0.01% 11174
2026
Q1
$512K Buy
226,687
+176,583
+352% +$371K ﹤0.01% 9599
2025
Q4
$49.8K Sell
50,104
-17,820
-26% -$10.9K ﹤0.01% 11750
2025
Q3
$33.8K Sell
67,924
-132,027
-66% -$71.2K ﹤0.01% 11955
2025
Q2
$112K Buy
199,951
+142,516
+248% +$76.5K ﹤0.01% 11721
2025
Q1
$27.3K Buy
57,435
+24,040
+72% +$18.1K ﹤0.01% 12038
2024
Q4
$33.7K Buy
+33,395
New +$45.5K ﹤0.01% 11813
2024
Q1
– Sell
-22,629
Closed -$75.1K – 12720
2023
Q4
$75.1K Buy
+22,629
New +$41.2K ﹤0.01% 11516
2023
Q2
– Sell
-10,747
Closed -$37.3K – 12596
2023
Q1
$37.3K Buy
+10,747
New +$47.2K ﹤0.01% 11826
2022
Q3
– Sell
-14,152
Closed -$149K – 13643
2022
Q2
$119K Buy
+14,152
New +$139K ﹤0.01% 11289
2021
Q3
– Sell
-23,001
Closed -$675K – 13137
2021
Q2
$675K Buy
+23,001
New +$584K ﹤0.01% 8834

Other funds holding IPSC

Jeff Yass's IPSC Position: Q3 2026 in Review

Jeff Yass reduced its Century Therapeutics (IPSC) stake by 91% in Q3 2026, selling an estimated $215K and leaving 10,605 shares worth $18.1K. The position accounts for ﹤0.01% of the portfolio, ranked #13146.

Jeff Yass first reported a position in IPSC in Q2 2021 and has held it in 12 quarters since. The position peaked at $675K in Q2 2021. 102 funds tracked by Wall St. Rank hold IPSC as of Q3 2026.

  • Jeff Yass held 10,605 shares of Century Therapeutics worth $18.1K as of Q3 2026.
  • Jeff Yass sold 105,187 Century Therapeutics shares in Q3 2026, an estimated $215K.
  • Century Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #13146 holding.
  • Jeff Yass first reported a position in Century Therapeutics in Q2 2021 and has held it in 12 quarters since.
  • Jeff Yass's Century Therapeutics position peaked at $675K in Q2 2021.
  • 102 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.